Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-039477
Filing Date
2022-03-29
Accepted
2022-03-29 16:30:55
Documents
2
Period of Report
2022-03-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2210715-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2210715-1_3seq1.xml 3 8052
2 EXHIBIT 24 tm2210715d1_ex24.htm EX-24 8646
  Complete submission text file 0001104659-22-039477.txt   18185
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Issuer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JAGUAR HEALTH INC., 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address
Chaturvedi Pravin R (Reporting) CIK: 0001916935 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36714 | Film No.: 22781308